SCHEMBL3852525

SCHEMBL3852525

CC(C)(C)C(=O)Nc1cccc(N2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cc34)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.48
CYP3A4 P08684 9/20 0.43
CLK4 Q9HAZ1 8/20 0.43
CYP1A2 P05177 7/20 0.43
LMNA P02545 6/20 0.43
MAPK1 P28482 6/20 0.43
HIF1A Q16665 6/20 0.43
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
USP2 O75604 5/20 0.41
AURKB Q96GD4 3/20 0.41
KIT P10721 2/20 0.40
CYP2D6 P10635 2/20 0.39
ALOX15 P16050 1/20 0.39
CYP2C19 P33261 1/20 0.39
PDGFRB P09619 4/20 0.38
HPGD P15428 1/20 0.38
JAK2 O60674 1/20 0.38
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3853439 0.86 CLK4 (0.42) CYP3A4CLK4CYP1A2LMNAMAPK1
SCHEMBL4716051 0.85 CLK4 (0.43) CYP3A4CLK4CYP1A2LMNAMAPK1
SCHEMBL3845891 0.85 ACHE (0.47) CYP3A4CLK4CYP1A2LMNAMAPK1
SCHEMBL3847121 0.84 MAPT (0.50) CYP3A4CLK4CYP1A2LMNAMAPK1
SCHEMBL5852369 0.84 CYP1A2 (0.43) MAP4K4CYP3A4CLK4CYP1A2LMNA
SCHEMBL3845844 0.83 PHGDH (0.47) CYP3A4CLK4CYP1A2LMNAMAPK1
SCHEMBL3846042 0.81 ABCG2 (0.47) CYP3A4CLK4CYP1A2LMNAMAPK1
SCHEMBL4761308 0.80 SIRT2 (0.42) CYP3A4CLK4CYP1A2LMNAMAPK1
Trifluoroacetic Acid SCHEMBL3846430 0.79 AKT1 (0.48) MAP4K4CYP3A4CLK4CYP1A2LMNA
SCHEMBL3846795 0.77 CYP1A2 (0.59) CYP3A4CLK4CYP1A2LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed